Tanguler Tolga's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed Mar 5, 2025
- Accession no.
- 0001735276-25-000033
- Filed
- Mar 5, 2025
- Trade date
- Mar 3, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $114.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tanguler TolgaCIK 0001849458 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | AGrant or awardAcquired | +14,137 | $0.00 | $0 | 28,482 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −131 | $242.37 | −$31,750.47 | 28,351 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −142 | $243.36 | −$34,557.12 | 28,209 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −96 | $244.41 | −$23,463.36 | 28,113 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −70 | $245.26 | −$17,168.2 | 28,043 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −29 | $246.18 | −$7,139.22 | 28,014 | Direct | |
| Mar 3, 2025 | Common Stock | SSaleDisposed | −3 | $247.35 | −$742.05 | 28,011 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Common Stock | AGrant or awardAcquired | +7,819 | $0.00 | $0 | 7,819 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.